Study of rare cancer identifies patients at highest risk of metastasis and those who would respond to immunotherapy

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Study of rare cancer identifies patients at highest risk of metastasis and those who would respond to immunotherapy CNIO_Cancer NatureComms

CNIO researchers Bruna Calsina and Mercedes Robledo. Credit: Laura M. Lombardía, CNIO

Mercedes Robledo, head of the Hereditary Endocrine Cancer Group at the Spanish National Cancer Research Center and one of the two researchers who led the study, has been studying these tumors since 1996. He says,"One of the difficulties of working with that our study gathers corresponds to a population of 100 million people." This has been possible thanks to the collaboration between 16 centers from six countries around the world, with which the CNIO has been collaborating for the last decade.

As Robledo and Calsina explain, most patients with this type of tumor who develop metastasis do so one or two years after the diagnosis of the disease, but there are cases in which metastasis develops ten or twenty years after the initial diagnosis. The new molecular markers will help clinicians to follow more closely those patients at high risk of metastasis.Another problem with this rare disease is that the therapies do not always work, and the reason is unknown.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study supports the concept of atherosclerosis as a T-cell autoimmune disease targeting the arterial wallStudy supports the concept of atherosclerosis as a T-cell autoimmune disease targeting the arterial wall NatureCVR LMU_Muenchen atherosclerosis Tcell autoimmune artery immune immunity disease
Source: NewsMedical - 🏆 19. / 71 Read more »

New study finds forgoing one food may treat eosinophilic esophagitis as well as excluding sixEliminating animal milk alone from the diet of adults with eosinophilic esophagitis (EoE) is as effective at treating the disease as eliminating animal milk plus five other common foods, a new clinical trial has found. For people with EoE whose disease remains active after they forgo animal milk, a more restrictive diet may help them achieve remission, according to the researchers. These findings were published today in the journal The Lancet Gastroenterology & Hepatology.
Source: medical_xpress - 🏆 101. / 51 Read more »